홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Triethylamine → (1S,4R)-4,7,7-Trimethyl-3-oxo-2-oxa-bicyclo[2.2.1]heptane-1-carboxylic acid (4R)-8-{(2R,3R,4R)-2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-tetrahydropyran-4-ylmethyl}-2-oxa-8-aza-spiro[4.5]dec-4-yl ester

HRID 747000
인쇄

반응식

HRID 747000 반응식
C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].[F:15][C:16]([F:46])([F:45])[C:17]1[CH:18]=[C:19]([C@H:27]([O:29][C@@H:30]2[C@@H:35]([C:36]3[CH:41]=[CH:40][C:39]([F:42])=[CH:38][CH:37]=3)[C@H:34]([CH:43]=O)[CH2:33][CH2:32][O:31]2)[CH3:28])[CH:20]=[C:21]([C:23]([F:26])([F:25])[F:24])[CH:22]=1.FC(F)(F)C(O)=O.[CH2:54]1[C:58]2([CH2:63][CH2:62][NH:61][CH2:60][CH2:59]2)[C@@H:57]([O:64][C:65]([C@@:67]23[C:73]([CH3:75])([CH3:74])[C@@:70]([CH3:76])([CH2:71][CH2:72]2)[C:69](=[O:77])[O:68]3)=[O:66])[CH2:56][O:55]1.C(N(CC)CC)C>ClCCl>[F:46][C:16]([F:15])([F:45])[C:17]1[CH:18]=[C:19]([C@H:27]([O:29][C@@H:30]2[C@@H:35]([C:36]3[CH:37]=[CH:38][C:39]([F:42])=[CH:40][CH:41]=3)[C@H:34]([CH2:43][N:61]3[CH2:62][CH2:63][C:58]4([CH2:54][O:55][CH2:56][C@@H:57]4[O:64][C:65]([C@@:67]45[C:73]([CH3:74])([CH3:75])[C@@:70]([CH3:76])([CH2:71][CH2:72]4)[C:69](=[O:77])[O:68]5)=[O:66])[CH2:59][CH2:60]3)[CH2:33][CH2:32][O:31]2)[CH3:28])[CH:20]=[C:21]([C:23]([F:24])([F:25])[F:26])[CH:22]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 8471TriethylamineHCID 5049666Sodium triacetoxyborohydrideHCID 86601740(2R,3R,4R)-2-[(1R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-tetrahydropyran-4-carbaldehydeHCID 86606912(1S,4R)-4,7,7-trimethyl-3-oxo-2-oxa-bicyclo[2.2.1]heptane-1-carboxylic acid (4R)-2-oxa-8-aza-spiro[4.5]dec-4-yl ester trifluoroacetate

생성물 1

HCID 86606911
(1S,4R)-4,7,7-Trimethyl-3-oxo-2-oxa-bicyclo[2.2.1]heptane-1-carboxylic acid (4R)-8-{(2R,3R,4R)-2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-tetrahydropyran-4-ylmethyl}-2-oxa-8-aza-spiro[4.5]dec-4-yl ester
수율 44.2%

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

Solid sodium triacetoxyborohydride (107 mg, 0.504 mmol) was added to a stirred mixture of 2-[1-{(2R,3R,4R)-2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-tetrahydropyran-4-carbaldehyde (Description 11; 121 mg, 0.36 mmol), (1S,4R)-4,7,7-trimethyl-3-oxo-2-oxa-bicyclo[2.2.1]heptane-1-carboxylic acid (4R)-2-oxa-8-aza-spiro[4.5]dec-4-yl ester trifluoroacetate (Description 10; 130 mg), triethylamine (0.1 ml, 0.72 mmol) and dichloromethane (3 ml) at room temperature. The mixture was stirred for 45 minutes, quenched with saturated aqueous NaHCO3 and extracted into dichloromethane. The organic extract was dried (Na2SO4) and concentrated. The residue was purified by preparative TLC (dichloromethane:methanol) to give the title compound (100 mg). The HCl salt was prepared and recrystallised from ethyl acetate:methanol.

후처리

  1. customquenched with saturated aqueous NaHCO3
  2. extractionextracted into dichloromethane
  3. extractionThe organic extract
  4. dry with materialwas dried (Na2SO4)
  5. concentrationconcentrated
  6. customThe residue was purified by preparative TLC (dichloromethane:methanol)

출처 및 근거

ORD 기록
ord-586e6d7867a8475cbee1cb0867d77a31
출처 데이터셋
uspto-grants-2008_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07393858B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트